LIGAND PHARMACEUTICALS INC's ticker is and the CUSIP is 53220KAF5. A total of 26 filers reported holding LIGAND PHARMACEUTICALS INC in Q1 2023. The put-call ratio across all filers is - and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $9,791,809 | – | 9,863,000 | – | 6.55% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Penn Mutual Asset Management | 1,214,000 | $1,164,000 | 1.57% |
| TFG Asset Management GP Ltd | 21,600,000 | $21,027,000 | 1.44% |
| TENOR CAPITAL MANAGEMENT Co., L.P. | 11,645,000 | $11,336,000 | 0.26% |
| OAKTREE CAPITAL MANAGEMENT LP | 20,472,000 | $19,704,000 | 0.23% |
| PALISADE CAPITAL MANAGEMENT, LP | 5,952,000 | $5,782,000 | 0.16% |
| SSI INVESTMENT MANAGEMENT LLC | 2,000,000 | $1,916,000 | 0.12% |
| Cutler Capital Management, LLC | 300,000 | $287,000 | 0.11% |
| Radcliffe Capital Management, L.P. | 3,117,000 | $2,985,000 | 0.07% |
| PROSPECTOR PARTNERS LLC | 400,000 | $383,000 | 0.06% |
| Financial Sense Advisors, Inc. | 130,000 | $125,000 | 0.05% |